Emmaus Life Sciences Analysis

Emmaus Pink Sheet Analysis Notes

About 39.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Emmaus Life Sciences last dividend was issued on the 18th of July 2019. The entity had 1:6 split on the 18th of July 2019. Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.The quote for Emmaus Life Sciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Emmaus Life Sciences call MD MPH at 310 214 0065 or check out https://www.emmausmedical.com.

Emmaus Life Sciences Investment Alerts

Emmaus Life Sciences Upcoming and Recent Events

Emmaus Life Thematic Classifications

Emmaus Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Emmaus Life's market, we take the total number of its shares issued and multiply it by Emmaus Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Emmaus Profitablity

The company has Profit Margin (PM) of (1.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.65.

Emmaus Life Outstanding Bonds

Emmaus Life Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Emmaus Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Emmaus shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Emmaus Life. By using and applying Emmaus Pink Sheet analysis, traders can create a robust methodology for identifying Emmaus entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.